The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.
Open accessAbstract
The T helper type 2 (Th2) cell product interleukin 10 (IL-10) inhibits the proliferation and function of Th1 lymphocytes and macrophages (M phi). The nonobese diabetic mouse strain (NOD/Shi) develops a M phi and T cell-dependent autoimmune diabetes that closely resembles human insulin-dependent diabetes mellitus (IDDM). The objective of the present study was to explore the consequences of localized production of IL-10 on diabetes development in NOD/Shi mice. Surprisingly, local production of IL-10 accelerated the onset and increased the prevalence of diabetes, since diabetes developed at 5-10 wk of age in 92% of IL-10 positive I-A beta g7/g7, I-E- mice in first (N2) and second (N3) generation backcrosses between IL-10 transgenic BALB/c mice and (NOD/Shi) mice. None of the IL-10 negative major histocompatibility complex-identical littermates were diabetic at this age. Furthermore, diabetes developed in 33% of I-A beta g7/d, I-E+ N3 mice in the presence of IL-10 before the mice were 10 wk old. Our findings support the notion that IL-10 should not simply be regarded as an immunoinhibitory cytokine, since it possesses powerful, immunostimulatory properties as well. Furthermore, our observations suggest that beta cell destruction in NOD mice may be a Th2-mediated event.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,385
Following a diabetogenic T cell from genesis through pathogenesis
Katz, J. D., Wang, B., Haskins, K., Benoist, C., & Mathis, D. (1993) · Cell · doi:10.1016/0092-8674(93)90730-e · Cited by 696
IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages
Gazzinelli, R. T., Oswald, I. P., James, S. L., & Sher, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.6.1792 · Cited by 694
The NOD Mouse: Recessive Diabetogenic Gene in the Major Histocompatibility Complex
Hattori, M., Buse, J. B., Jackson, R. A., Glimcher, L., Dorf, M. E., Minami, M., Makino, S., Moriwaki, K., Kuzuya, H., Imura, H., et al. (1986) · Science · doi:10.1126/science.3003909 · Cited by 418
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells
Yssel, H., De Waal Malefyt, R., Roncarolo, M. G., Abrams, J. S., Lahesmaa, R., Spits, H., & de Vries, J. E. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.7.2378 · Cited by 406
The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.
Acha-Orbea, H., & McDevitt, H. O. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2435 · Cited by 398
IL-10: a novel cytotoxic T cell differentiation factor
Chen, W. F., & Zlotnik, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.528 · Cited by 382
Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice
Wicker, L. S., Miller, B. J., & Mullen, Y. (1986) · Diabetes · doi:10.2337/diab.35.8.855 · Cited by 381
Ding, L., & Shevach, E. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.3133 · Cited by 363
Goldman, M., Druet, P., & Gleichmann, E. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90034-q · Cited by 358
Oswald, I. P., Wynn, T. A., Sher, A., & James, S. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8676 · Cited by 353
Lund, T., O'Reilly, L., Hutchings, P., Kanagawa, O., Simpson, E., Gravely, R., Chandler, P., Dyson, J., Picard, J. K., Edwards, A., et al. (1990) · Nature · doi:10.1038/345727a0 · Cited by 331
de Waal Malefyt, R., Hans, Y., Roncarolo, M.-G., Spits, H., & de Vries, J. E. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90082-p · Cited by 312
Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice
Nishimoto, H., Kikutani, H., Yamamura, K.-I., & Kishimoto, T. (1987) · Nature · doi:10.1038/328432a0 · Cited by 301
Three Recessive Loci Required for Insulin-Dependent Diabetes in Nonobese Diabetic Mice
Prochazka, M., Leiter, E. H., Serreze, D. V., & Coleman, D. L. (1987) · Science · doi:10.1126/science.2885918 · Cited by 290
Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production
Macatonia, S. E., Doherty, T. M., Knight, S. C., & O’Garra, A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.3755 · Cited by 243
te Velde, A. A., de Waal Malefijt, R., Huijbens, R. J., de Vries, J. E., & Figdor, C. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.4048 · Cited by 217
Miyazaki, T., Uno, M., Uehira, M., Kikutani, H., Kishimoto, T., Kimoto, M., Nishimoto, H., Miyazaki, J.-I., & Yamamura, K.-I. (1990) · Nature · doi:10.1038/345722a0 · Cited by 200
Wogensen, L., Huang, X., & Sarvetnick, N. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.175 · Cited by 174
Self-citationI-E+ nonobese diabetic mice develop insulitis and diabetes.
Podolin, P. L., Pressey, A., DeLarato, N. H., Fischer, P. A., Peterson, L., & Wicker, L. S. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.793 · Cited by 132
Genetic Control of Diabetogenesis in NOD/Lt Mice: Development and Analysis of Congenic Stocks
Procházka, M., SERREZE, D. V., Worthen, S. M., & Leiter, E. H. (1989) · Diabetes · doi:10.2337/diab.38.11.1446 · Cited by 87
Development of autoimmune insulitis is prevented in Eαd but not in Aβk NOD transgenic mice
Uehira, M., Uno, M., Kürner, T., Kikutani, H., Mori, K.-I., Inomoto, T., Uede, T., Miyazaki, J., Nishimoto, H., Kishimoto, T., et al. (1989) · International Immunology · doi:10.1093/intimm/1.2.209 · Cited by 87
Anderson, J. T., Cornelius, J., Jarpe, A. J., Winter, W. E., & Peck, A. B. (1993) · Autoimmunity · doi:10.3109/08916939309043886 · Cited by 70
T-cell subsets in autoimmunity
Mason, D., & Fowell, D. J. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90053-h · Cited by 50
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146
Munder, M., Eichmann, K., & Modolell, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5347 · Cited by 647
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
T Helper Cell Subsets in Insulin-Dependent Diabetes
Katz, J. D., Benoist, C., & Mathis, D. (1995) · Science · doi:10.1126/science.7761837 · Cited by 593
Metadata
- Authors
- Wogensen, L., Lee, M. S., & Sarvetnick, N.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-04-01
- Volume
- 179
- Issue
- 4
- Pages
- 1379-1384
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2169056709
- Cited by
- 294
- References
- 27
- FWCI
- 14.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.